Introduction
Malaria as one of the oldest recorded diseases is considered as the major parasitic disease in tropical and subtropical areas of the world, imposing significant morbidity and often mortality where they occur. 1, 2 Each year more than 216 million new cases and approximately 655000 deaths of malaria are diagnosed and recorded, most of which are children. 3, 4 This global ailment is caused by Plasmodium species, of which P. falciparum is the most deadly pathogen, and is accountable for over 85% of cases. 5, 6 In Iran, malaria is one of the most crucial parasitic diseases in the south-eastern areas, responsible for around 95% of all malaria cases in the country. 3 Chloroquine was synthesized for the first time in 1934 and designated as the chosen drug for treatment of malaria in 1946. It is known as the cheapest and commonly used drug for the treatment of malaria. 5, 7, 8 Chloroquine is thought to display its antimalarial activity by inhibiting the crystallization of toxic heme produced during proteolysis of hemoglobin in the parasite vacuoles. 9 Unfortunately, this medication has become ineffective due to the generation of chloroquine-resistant species of the malaria parasite. 5, 7, 8 Nowadays, medicinal plants, as a new resource, are popular and utilized in the prevention and treatment of malaria in different parts of the world. [6] [7] [8] 10, 11 For instance, artemisinin as a natural product from an indigenous herb in China, was derived from the plant Artemisia annua in 1972. It has been growing attention to this plant since the isolation of artemisinin because of its distinguished clinical effects as a potent antimalarial agent. 7, [12] [13] [14] Artemisinin with an endoperoxide sesquiterpene lactone structure can abolish parasite of all stages by a reductive interaction with free heme, resulting in generation of some types of free radicals that could alkylate parasite proteins and damage membranes. Artemisinin also acts by blocking free heme biocrystallization (like 4-aminoquinolines) and hemoglobin degradation.
14 World Health Organization (WHO) recommended artemisinin-based combination therapy (ACT) as the first-line treatment of unsophisticated malaria in April 2002. 15 In the last few years, WHO has recommended withdrawal of the oral artemisininbased monotherapies from the market due to the risk of emergence of artemisinin-resistant parasites; 14, 16 38 According to previous studies containing traditional knowledge and clinical findings, a number of Eremostachys species are applied as local analgesic and anti-inflammatory agents. Also this genus has shown antinociceptive, antidepressant and antibacterial activities. [39] [40] [41] [42] [43] [44] The main objectives of this study were to investigate on (a) the antimalarial activity of different extracts of aerial parts and rhizomes of this plant, (b) fractionation of the most potent extract, (c) determination of the most potent fractions, and (d) identification of the chemical composition of them by GC-MS.
Materials and methods

Chemicals
All the solvents used for extraction and fractionation were purchased from Caledon Labs (Halton Hills, Ontario, Canada). Hematin porcine, chloroquine diphosphate, sodium dodecyl sulfate (SDS), sodium acetate, magnesium sulfate, sodium hydrogen phosphate, sodium chloride, potassium chloride, sodium hydroxide, glucose, and sodium bicarbonate were purchased from Sigma-Aldrich Company Ltd (Dorset, United kingdom). Oleic acid was obtained from Fluka (Gujarat, India) and dimethylsulfoxide, hydrochloric acid, and silica gel 60 (0.040-0.063 mm) from Merck company (Darmstadt, Germany).
Plant material
The aerial parts and rhizomes of E. macrophylla 
Extraction
Air-dried and ground aerial parts and rhizomes of E. macrophylla (100 g each) were Soxhlet extracted respectively with n-Hexane, DCM, and methanol (MeOH) (1 L each). All obtained extracts were separately concentrated using a rotary evaporator at a maximum temperature of 45°C.
Fractionation
An amount of 1.1 g of DCM extract from rhizomes of E. macrophylla was fractionated by vacuum liquid chromatography (VLC) over silica gel (20 g ) with solvent mixtures of increasing polarities: ethyl acetate/n-hexane (i.e., at ratios of 10:90; 20:80; 40:60; 60:40; 80:20; 100:0) and methanol. All the fractions were fully dried using a rotary evaporator at a maximum temperature of 45°C.
Antimalarial cell free assay
Antimalarial activity of plant extracts was evaluated by the method explained by Afshar et al 45 with some modifications. Briefly, varying concentrations (0-2 mg/mL in DMSO) of the extracts and fractions were produced. The reaction mixtures were incubated with 3 mM of hematin, 10.0 mM oleic acid, and 1 M HCl. The final volume was adjusted to 1.0 mL volume using sodium acetate buffer, pH 5, overnight at 37°C with constant gentle shaking. Chloroquine diphosphate was used as a positive control. After incubation, samples were centrifuged (14000 rpm, 10 min, at 21°C) and the hemozoin pellet was repeatedly washed with incubation (15 min at 37°C with regular shaking) in 2.5% (w/v) SDS in phosphate buffered saline followed by a final wash in 0.1 M sodium bicarbonate until the supernatant was clear (usually 3-8 washes). After the final wash, the supernatant was discarded and the pellets were dissolved in 1.0 mL of 0.1 M NaOH before determining the hemozoin content by measuring the absorbance at 400 nm (Spectronic Genesys spectrophotometer). The results were recorded as % inhibition (I%) of heme crystallization compared to negative control (DMSO) using the following equation: I% = [(AN−AS)/AN]×100, where, AN is absorbance of negative control and AS is absorbance of test samples.
GC-MS analysis of potent fractions
GC-MS analyses were carried out on a Shimadzu QP-5050A GC-MS system (Shimadzu Corp., Kyoto, Japan) equipped with a DB-1 fused silica column (60 m × 0.25 mm i.d., film thickness 0.25 µm); oven temperature, rising from 100°C to 310°C at a rate of 5°C; injector temperature, 280°C; carrier gas, helium at a flow rate of 1.0 mL/min; split ratio, 1:19; ionization energy, 70 eV; scan time, 1 s; mass range, 30-600 amu.
Identification of components
Identification of the components was based on direct comparison of the retention times and mass spectral 
Statistical analysis
All experiments were performed in triplicate and presented as the Mean ± SD. Data were analyzed by Microsoft Excel 2010. The IC 50 and IC 90 values were calculated by nonlinear regression analysis.
Results
The results from the cell free β-hematin formation assay of six different extracts from aerial parts and rhizomes of E. macrophylla and seven fractions of the most potent extract as well as the extraction and fractionation yields are listed in Table 1 . The inhibition of β-hematin formation represented as percentage (I %) and standard deviations (n = 3) are considered for each extract/fraction. The values of IC 50 and IC 90 were measured graphically by plotting concentrations versus percentage of inhibition.
Chloroquine was used as positive control with the most potent antimalarial activity and the extracts solvent (DMSO) was used as negative control without any antimalarial activity.
As shown in Table 1 , n-Hexane and methanol extracts of aerial parts and rhizomes had no antimalarial activity at all while the DCM extracts of both parts especially DCM extract of rhizomes showed the most potent antimalarial activity compared to the standard antimalarial compound, chloroquine (IC 50 = 0.014 ± 0.003 mg/mL, IC 90 = 0.163 ± 0.004 mg/mL). IC 50 values of DCM extract of aerial parts and rhizomes were 0.797 ± 0.016 and 0.324 ± 0.039 mg/ mL, respectively. This was 0.863 ± 0.018 and 0.753 ± 0.009 mg/mL for IC 90 values of this extract, respectively. As shown in Table 1 and Fig. 1 (Table 1) .
Discussion
Malaria is a life-threatening disease caused by the Anopheles mosquitoes that infects the human body by intracellular parasite of the genus Plasmodium.
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Plasmodium falciparum utilizes host hemoglobin as a main nutrient source for its growth and reproduction. This parasite ingests more than 75% of the host hemoglobin during intra-erythrocytic cycle; therefore, substantial amounts of heme is generated as a toxic by-product from massive degradation of hemoglobin. 47, 48 Subsequently, parasite for protecting itself from the self-produced toxic material has evolved a process through the crystallization of heme into an insoluble, nontoxic crystalline pigment known as hemozoin. 14, 49, 50 Hemozoin is equivalent to β-hematin, which consists of cyclic heme dimers arranged in an ordered crystalline structure through intermolecular hydrogen bonding. It is believed to be the most validated target of detoxification. Therefore, the inhibition of hemozoin formation is a way for drug screening programs. Many different quantitative in vitro methods based on spectral characteristics and differential solubility of monomeric heme and β-hematin has been used for evaluation of antimalarial activities. 48, [51] [52] [53] In this study, 6 extracts and 7 fractions of aerial parts and rhizomes of E. macrophylla were evaluated for their antimalarial activity by an in vitro method. Our findings revealed that the n-hexane and the MeOH extracts of both parts of E. macrophylla did not show any significant antimalarial activities but the DCM extracts of both aerial parts and rhizomes showed significant potential antimalarial effects in comparison with negative control. It was indicated that potent antimalarial constituents of active extracts might possess medium polarity. Among two DCM extracts of E. macrophylla, DCM extract of rhizomes demonstrated the most potent activity (IC 50 =0.324 ± 0.039 mg/mL , IC 90 = 0.753 ± 0.009mg/mL) which guided to fractionate it by VLC over silica gel with solvent mixtures of increasing polarities (Fig. 2) . Based upon the results presented in Table 1 and Fig. 1 , among the seven fractions obtained by VLC, the 60% ethyl acetate/n-hexane fraction was the most potent fraction with IC 50 value of 0.047 ± 0.0003 and IC 90 value of 0.249 ± 0.023 mg/mL. Other polar fractions, 80% ethyl acetate/n-hexane, 100% ethyl acetate/n-hexane and 100% MeOH, also were determined as significantly potent antimalarial fractions. GC-MS analysis of fractions with antimalarial activity indicated the presence of steroids, polycyclic aromatic hydrocarbon, diterpenoid derivatives, linear alcohols and fatty acids as major constituents. Previous investigations showed that terpenes, steroids, coumarins, flavonoids, phenolic acids, stilbenes, lignans and alkaloids exhibited antiplasmodial activity in different antimalarial assays. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] Based on the results shown in Table 2 , in 60% ethyl acetate/n-hexane fraction, steroidal structures were identified as the major active constituents (about 82%). Therefore, it seems that the strong antimalarial activity of this fraction might be related to the presence of steroids derivatives. In the case of 80% ethyl acetate/n-hexane and 100% ethyl acetate fractions, fatty acid, polycyclic aromatic hydrocarbon, steroids and their derivatives were identified by GC-MS analysis. Additionally, in 100% MeOH fraction, the presence of fatty acids, steroids and diterpenoid derivatives were determined. Moreover, based on previous researches, the presence of lipids and other fatty acids in the mixture of active extracts and fractions showed synergistic effects with oleic acid in assay; therefore, the recorded absorbances were higher than the negative control. It was exhibited that the values of IC 50 and IC 90 could be reduced by entirely eliminating the fatty acids and purifying the active antimalarial constituents. 14, 45 The percentage of fatty acids and their derivatives in 100% MeOH fraction (23.14%) was higher than that in 80% ethyl acetate/n-hexane (5.60%) and 100% ethyl acetate (3.46%) fractions; so the IC 50 and IC 90 values of 100% MeOH fraction can be extremely reduced by completely removing of fatty acid derivatives. In consideration of high yields of 100% MeOH fraction (68.18% of DCM extract) as compared to other active fractions (Table 1) , more purification of this fraction would be valuable. Taken all, based on the GC-MS analysis of VLC fractions and previous studies, it seems that steroid derivatives and diterpenes are as the major active antimalarial constituents in DCM extract of rhizomes. Among the seven different polarity fractions, 20% ethyl acetate/n-hexane and 40% ethyl acetate/n-hexane fractions revealed no activity in this assay system, while the last four polar fractions showed the potent activity with close IC 50 and IC 90 values (Table 1 and Fig. 1 ).
Conclusion
From 6 extracts with different polarity of E. macrophylla , s aerial parts and rhizomes, the DCM extract of both parts were the most active extract in the cell free β-hematin formation assay. The preliminary phytochemical study on the VLC fractions of the most potent part (DCM extract of rhizomes) produced compelling results that led us to focus on purifying the active components of these extracts and investigating further on animal models for in vivo evaluation.
Ethical issues
Not applicable in this study. What is new here? √ DCM extract from rhizomes of E. macrophylla showed antimalarial activity in in vitro β-hematin formation assay. √ Fractionation of DCM extract and evaluation of them by GC-MS suggested that steroidal compounds may be responsible for antimalarial activity.
